Platte River Wealth Advisors, LLC Pfizer Inc Transaction History

Platte River Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 07, 2023	SELL	$39.39 - $51.28 $424,702 - $552,900	-10,782 Reduced 65.64%	5,645 $230,000
Q4 2022 Jan 13, 2023	BUY	$41.75 - $54.5 $154,892 - $202,195	3,710 Added 29.17%	16,427 $0
Q3 2022 Oct 21, 2022	BUY	$43.76 - $53.42 $214,642 - $262,025	4,905 Added 62.79%	12,717 $556,000
Q2 2022 Jul 08, 2022	BUY	$46.53 - $55.17 $363,492 - $430,988	7,812 New	7,812 $410,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Platte River Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Platte River Wealth Advisors, LLC with notifications on news.